Sexual Dysfunctions in Men Affected by Autoimmune Addison's Disease Before and After Short-Term Gluco- and Mineralocorticoid Replacement Therapy
- 1 August 2013
- journal article
- Published by Oxford University Press (OUP) in The Journal of Sexual Medicine
- Vol. 10 (8) , 2036-2043
Abstract
Introduction There is evidence suggesting that autoimmune Addison's disease (AD) could be associated with sexual dysfunctions probably caused by gluco‐ and mineralocorticoid deficiency; however, no study has yet treated this subject in males. Aim To evaluate male sexuality and psychological correlates in autoimmune AD before and after gluco‐ and mineralocorticoid replacement therapy. Methods Twelve subjects with a first diagnosis of autoimmune AD were studied before (baseline) and 2 months after (recovery phase) initiating hormone replacement therapy. Main Outcome Measures Erectile function (EF), orgasmic function (OF), sexual desire (SD), intercourse satisfaction (IS), overall satisfaction (OS), depression, and anxiety were studied using a number of questionnaires (International Index of Erectile Function, Beck Depression Inventory, and Spielberger State‐Trait Anxiety Inventory); clinical, biochemical, and hormone data were included in the analysis. Results At baseline, low values were found for EF, OF, SD, IS, and OS and high values for depression and anxiety; all of these parameters improved significantly in the recovery phase compared with baseline. EF variation between the two phases correlated significantly and positively with the variation of serum cortisol, urinary free cortisol, systolic blood pressure, and diastolic blood pressure and inversely with that of upright plasma renin activity. Multiple linear regression analysis using EF variation as dependent variable confirmed the relationship of the latter with variation of serum cortisol, urinary free cortisol, and upright plasma renin activity but not with variation of systolic and diastolic blood pressure. Conclusions Our study showed that onset of autoimmune AD in males is associated with a number of sexual dysfunctions, all reversible after initiating replacement hormone therapy; cortisol and aldosterone deficiency seems to play an important role in the genesis of erectile dysfunction although the mechanism of their activity is not clear. Granata A, Tirabassi G, Pugni V, Arnaldi G, Boscaro M, Carani C, and Balercia G. Sexual dysfunctions in men affected by autoimmune Addison's disease before and after short‐term gluco‐ and mineralocorticoid replacement therapy. J Sex Med 2013;10:2036–2043.Keywords
This publication has 24 references indexed in Scilit:
- Programming Effects of Antenatal Corticosteroids Exposure in Male Sexual BehaviorThe Journal of Sexual Medicine, 2011
- Effects of single cortisol administrations on human affect reviewed: Coping with stress through adaptive regulation of automatic cognitive processingPsychoneuroendocrinology, 2011
- Hypertensive Medication and Erectile DysfunctionCardiovascular Therapeutics, 2010
- The relationship of serum and salivary cortisol levels to male sexual dysfunction as measured by the International Index of Erectile FunctionInternational Journal Of Impotence Research, 2009
- Cortisol, Sexual Arousal, and Affect in Response to Sexual StimuliThe Journal of Sexual Medicine, 2008
- Long-Term DHEA Replacement in Primary Adrenal Insufficiency: A Randomized, Controlled TrialThe Journal of Clinical Endocrinology & Metabolism, 2008
- Sexual Symptoms in Endocrine Diseases: Psychosomatic PerspectivesPsychotherapy and Psychosomatics, 2007
- Adrenal InsufficiencyNew England Journal of Medicine, 1996
- AUTO‐IMMUNE ADDISON'S DISEASE ASSOCIATED WITH HYPERPROLACTINAEMIAClinical Endocrinology, 1984
- EPIDEMIOLOGICAL AND CLINICAL PICTURE OF ADDISON'S DISEASEThe Lancet, 1968